Pan, Xingyi
Zheng, Lei
Article History
Received: 20 May 2020
Accepted: 30 June 2020
First Online: 22 July 2020
Competing interests
: L.Z. receives grant support from Bristol-Myers Squibb, Merck, iTeos, Amgen, NovaRock, InxMed, and Halozyme. L.Z. is a paid consultant/Advisory Board Member at Biosion, Alphamab, NovaRock, Akrevia, DataRevive, and Mingruzhiyao. L.Z. holds shares of Alphamab and Mingruzhiyao.